Selaginella willdenowii
Selaginella willdenowii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Selaginella willdenowii is a unique plant species that has garnered significant attention in pharmacological research. Recent studies have focused on the biological activities of its leaf extracts, specifically investigating their potential cytotoxic properties. Through various preparations, researchers have isolated distinct fractions to evaluate their medicinal efficacy. These fractions contain important chemical compounds, including amentoflavone, bilobetin, isocryptomerin, and robustaflavone. Understanding these constituents is crucial for exploring the plant's future applications in cancer research and drug development.
- Synonyms
- Lycopodium Willdenowii · Lycopodioides Caespitosa · 10 more
- Common names
- Not available
- Family
- Selaginellaceae
- Distribution
- Northern America
- Plant Parts
- Leaf
Classification
Common Names
Selaginella willdenowii is a unique plant known by several distinct common names across different regions. It is frequently referred to as Willdenow's spikemoss or the Vine Spike-moss in botanical discussions. Many enthusiasts also admire its iridescent foliage, leading to its popular designation as the peacock fern. In certain European contexts, you may encounter it called Pfauen-Moosfarn. Additionally, it is sometimes recognized by the name Dailioji selaginelė.
Sources: Catalogue of Life (COL)
Synonyms
Selaginella willdenowii is a species that has been identified through various taxonomic classifications throughout botanical history. It is frequently associated with the synonym Didiclis willdenowii in several scientific records. Researchers have also cataloged this plant under the names Lycopodioides caespitosa and Lycopodioides willdenowii. Furthermore, the species is linked to the nomenclature Lycopodium caesium arboreum. Finally, the botanical literature often recognizes it by the synonym Lycopodium caespitosum.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Selaginella willdenowii is a fascinating biological specimen that belongs to the kingdom Plantae. Within this vast kingdom, it is specifically categorized under the class Equisetopsida. The plant is further defined by its placement in the order Selaginellales, which highlights its unique evolutionary lineage. It occupies the genus Selaginella, a group known for its distinct structural characteristics. Finally, its classification is completed by its membership in the family Selaginellaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Lycopodiidae |
| Order | Selaginellales |
| Family | Selaginellaceae |
| Genus | Selaginella |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Selaginella willdenowii boasts a diverse geographical range that spans across several key regions of Asia. In temperate zones, this plant is commonly found throughout various parts of China, including both South-Central and Southeast territories. Its presence extends into tropical climates as well, stretching across the Indian Subcontinent and into Bangladesh. The species also thrives within the Indo-China region, specifically inhabiting areas such as Cambodia and the Andaman Islands. This widespread distribution highlights the plant's ability to adapt to both temperate and tropical ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Selaginella willdenowii is a distinctive herb characterized by its unique botanical structure. This species possesses an obligatory climbing habit, requiring support to facilitate its natural growth pattern.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Selaginella willdenowii has demonstrated significant biological potential through the presence of bioactive biflavonoids within its leaves. Research involving bioactivity-guided fractionation has successfully identified specific compounds, such as 4',7"-di-O-methylamentoflavone, isocryptomerin, and 7"-O-methylrobustaflavone. These particular isolates have proven to be significantly cytotoxic against a variety of human cancer cell lines. While other components like amentoflavone were found to be non-cytotoxic, the identification of these active molecules remains a key finding. Furthermore, the study utilized advanced spectroscopic methods to unambiguously assign the structure of a newly discovered dihydrobiflavone.
Compounds
Selaginella willdenowii is a plant species known to harbor a variety of significant biflavonoids within its leaves. Through bioactivity-guided fractionation, researchers have identified several key compounds present in this species, including amentoflavone and bilobetin. The chemical profile of the plant also features isocryptomerin, which contributes to its complex phytochemical makeup. Additionally, the presence of robustaflavone has been confirmed through detailed spectroscopic analysis. These findings highlight the diverse chemical constituents that characterize the biological composition of Selaginella willdenowii.
Conditions
Selaginella willdenowii contains bioactive biflavonoids that exhibit significant anti-inflammatory activity, specifically through agents such as tetrahydrobilobetin and 2'',3''-dihydrobilobetin. The plant also demonstrates potent effects against human cancer cell lines, including A549, HepG2, and T47D. One specific compound, robustaflavone-7''-methyl ether, shows strong cytotoxicity and high selectivity against these malignant cells. This substance further treats these conditions by inducing apoptotic cell death through the elevation of reactive oxygen species levels. Consequently, these botanical properties highlight the plant's therapeutic potential in addressing inflammation and cancer.
Preparations
Selaginella willdenowii is prepared as various fractions to facilitate the identification of bioactive compounds. Researchers utilized these specific fractions to conduct bioassay-guided fractionation aimed at isolating biflavonoids. Through LC-MS-based metabolomic profiling, the properties of these fractions were analyzed to determine their anti-inflammatory potential. This preparation allowed for the successful detection of tetrahydrobilobetin and 2'',3''-dihydrobilobetin within the plant extracts. Consequently, the fractionation process proved essential in isolating robustaflavone-7''-methyl ether, which exhibited significant cytotoxicity against specific cancer cell lines.
Parts used
Selaginella willdenowii contains specialized leaf structures that serve as a rich source of bioactive compounds. Through bioactivity-guided fractionation of these leaves, researchers have successfully isolated several significant biflavonoids. Among these findings, specific molecules like 4',7"-di-O-methylamentoflavone have demonstrated notable cytotoxicity against various human cancer cell lines. The study also identified several non-cytotoxic isolates, including a newly discovered dihydrobiflavone. Ultimately, the structural properties of these leaf-derived compounds were precisely determined using advanced spectroscopic methods.